IL21R and psoriasis: Neutralizing IL-21R by antibody reduces IMQ-induced epidermal thickening through downregulating the infiltration of MDSCs and Th17 cells (Figure 5(d)), suggesting the accumulation of MDSCs exerts important function for the pathogenesis of psoriasis and IL-21 may be a potential therapeutic target in psoriasis.